바이오엔시스템스 주식회사

{
  "address": "경기도 의왕시",
  "ceo_name": "서정근",
  "certificate": [
    {
      "cert_number": "20210300089",
      "changes": "",
      "disclosure_date": "2021-01-28",
      "first_cert_date": "2021-01-28",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2021-01-28 ~ 2023-01-27"
    },
    {
      "cert_number": "20230125010046",
      "changes": "",
      "disclosure_date": "2023-01-25",
      "first_cert_date": "2021-01-28",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2023-01-28 ~ 2026-01-27"
    },
    {
      "cert_number": "20260113010002",
      "changes": "",
      "disclosure_date": "2026-01-13",
      "first_cert_date": "2021-01-28",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2026-01-28 ~ 2029-01-27"
    }
  ],
  "company_name": "바이오엔시스템스 주식회사",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 1356995000,
      "cost_of_sales": 0,
      "current_assets": 518313000,
      "current_liabilities": 3308398000,
      "gross_profit": 1309360000,
      "net_income": -4776631000,
      "net_income_bs": -4776631000,
      "non_current_assets": 1107497000,
      "non_current_liabilities": 37455000,
      "non_operating_expenses": 16974000,
      "non_operating_income": 61172000,
      "operating_profit": -4820829000,
      "revenue": 1309360000,
      "sga_expenses": 6130189000,
      "total_assets": 1625810000,
      "total_equity": -1720042000,
      "total_liabilities": 3345852000
    },
    "2023": {
      "capital_stock": 1356995000,
      "cost_of_sales": 0,
      "current_assets": 274632000,
      "current_liabilities": 2730443000,
      "gross_profit": 1497612000,
      "net_income": 55763000,
      "net_income_bs": 55764000,
      "non_current_assets": 838182000,
      "non_current_liabilities": 46650000,
      "non_operating_expenses": 16675000,
      "non_operating_income": 23471000,
      "operating_profit": 48967000,
      "revenue": 1497612000,
      "sga_expenses": 1448645000,
      "total_assets": 1112814000,
      "total_equity": -1664279000,
      "total_liabilities": 2777093000
    },
    "2024": {
      "capital_stock": 1356995000,
      "cost_of_sales": 0,
      "current_assets": 83477000,
      "current_liabilities": 2818742000,
      "gross_profit": 513180000,
      "net_income": -658034000,
      "net_income_bs": -658035000,
      "non_current_assets": 709602000,
      "non_current_liabilities": 296650000,
      "non_operating_expenses": 10420000,
      "non_operating_income": 96208000,
      "operating_profit": -743822000,
      "revenue": 513180000,
      "sga_expenses": 1257002000,
      "total_assets": 793079000,
      "total_equity": -2322313000,
      "total_liabilities": 3115393000
    }
  },
  "industry": "그 외 기타 분류 안된 전문, 과학 및 기술 서비스업",
  "investment": [
    {
      "amount": "5,084,993,000",
      "changes": "5,084,993,000",
      "date": "2020-01-06"
    },
    {
      "amount": "2,535,000,000",
      "changes": "2,535,000,000",
      "date": "2020-01-06"
    },
    {
      "amount": "2,535,000,000",
      "changes": "2,535,000,000",
      "date": "2020-01-06"
    },
    {
      "amount": "2,549,000,000",
      "changes": "2,549,000,000",
      "date": "2019-05-07"
    },
    {
      "amount": "2,549,992,500",
      "changes": "2,549,992,500",
      "date": "2019-05-07"
    }
  ],
  "main_products": "의학 및 약학 연구개발업",
  "phone": "031-348-****",
  "years": [
    2024,
    2023,
    2022
  ]
}